GeneNews' Q4 Revenues Drop Sharply | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews reported after the close of the market on Friday that revenues for the fourth quarter dropped to C$4,000 (US$4,101) for the three months ended Dec.31, 2010, down from C$410,000 a year ago.

The decline was due to lower revenue from milestone and non-refundable license fees, which plummeted to $C$1,643 from C$398,325, as GeneNews completed all of its historic research agreements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.